Archean Chemical Industries Ltd (ACI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Archean Chemical Industries Ltd on NSE and BSE, with an AI summary of each filing.
Earnings call recording
Audio / Video · 04 Nov 2026, 12:55 am
Archean Chemical Releases Q2 FY27 Earnings Call Audio Recording Archean Chemical Industries Limited has made available the audio recording of its Earnings Conference Call for the quarter and half-year ended 30th Sep'26. The call was conducted on 3rd Nov'26 at 2:30 PM following the company's prior intimation on 28th Oct'26. In compliance with Regulation 30 of SEBI LODR Regulations, the recording has been uploaded to the company's official website for investor access.
Presentation for the earnings call
Investor Presentation · 03 Nov 2026, 1:38 am
Archean Chemical Industries Reports Robust Q2FY27 Results and Strategic Expansion Archean Chemical Industries reported consolidated total income of Rs 301.6 crore for Q2FY27, rising 25.9% YoY, while EBITDA grew 7.9% YoY to Rs 74.5 crore and PAT increased to Rs 31.3 crore. Growth was driven by Bromine revenue surging 76% YoY to Rs 127.5 crore and Bromine Derivatives climbing 81% YoY to Rs 36 crore. Industrial Salt grew 9% YoY to Rs 161 crore despite temporary logistical issues. Progress continues on high-growth ventures, including the SiCSem semiconductor project and Zinc-Bromide battery initiatives with Offgrid Energy Labs.
Allotment of shares under Company Employee Stock Option Plan 2022
Others (Uncategorized) · 30 Oct 2026, 1:21 am
Archean Chemical Allots 6,143 Equity Shares Under ESOP 2022 Scheme The Board of Archean Chemical Industries Limited approved the allotment of 6,143 equity shares with a face value of Rs. 2 each on 29th Oct'26, following the exercise of stock options under its ACIL-Employee Stock Option Plan 2022. The allotment increases the company's total paid-up equity shares from 12,34,58,394 to 12,34,64,537, expanding the total issued share capital to Rs. 24,69,29,074. The newly issued shares rank pari-passu with existing equity shares, and the company will apply for listing and trading permissions shortly.
Please find enclosed the Unaudited Financial Results for the quarter & half year ended September 30, 2026
Financial Result · 30 Oct 2026, 12:12 am
Archean Chemical Industries Limited has submitted to the Exchange, the unaudited financial results for the quarter ended & half year ended September 30, 2026.
Outcome · 30 Oct 2026, 12:00 am
Please find enclosed the Board meeting Outcome 29.10.2026
Outcome · 29 Oct 2026, 11:54 pm
Archean Chemical Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 29,736 (+27.5% YoY | -9.1% QoQ) ■ EBITDA: 7,020 (+12.1% YoY | +4.4% QoQ) ■ EBITDA Margin (%): 23.6 (-324 bps YoY | +305 bps QoQ) ■ PAT: 3,206 (+10.2% YoY | +4.5% QoQ) ■ EPS (INR): 2.60 (+10.2% YoY | +4.8% QoQ)
Intimation of Schedule for Earnings Call
Intimation · 03 Nov 2026, 2:30 pm
Archean Chemical Industries Schedules Q2 & H1 FY27 Earnings Call Archean Chemical Industries Limited has scheduled its earnings conference call on 3rd Nov'26 at 02:30 PM IST to discuss the company's operational and financial performance for the quarter and half-year ended 30th Sep'26 (Q2 & H1 FY27). Senior management, including Managing Director Rampraveen Swaminathan, Chief Financial Officer Natarajan Ramamurthy, and DGM Finance Rajeev Kumar, will represent the company on the call.
Credit Rating
Others (Uncategorized) · 23 Oct 2026, 3:57 am
CRISIL Downgrades Archean Chemical’s Rating to ‘Crisil A-/Stable’ CRISIL downgraded Archean Chemical Industries' long-term bank facilities rating from 'CRISIL A/Negative' to 'Crisil A-/Stable' while expanding rated facilities from Rs 265 crore to Rs 1,531 crore. The downgrade reflects lower bromine sales volumes in FY26, delayed subsidiary ramp-ups, and elevated financial leverage. Total debt is projected to surge from Rs 466 crore as of 31st Mar'26 to Rs 1,300–1,500 crore to fund a revised Rs 2,500 crore SiC semiconductor project, raising net debt/EBITDA to 3.50–3.80x over the medium term.
ARCHEAN CHEMICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
ARCHEAN CHEMICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Un-Audited ....
Intimation · 29 Oct 2026, 5:30 am
Archean Chemical Schedules Board Meeting on 29th Oct'26 for Q2 Results Archean Chemical Industries Limited has scheduled a meeting of its Board of Directors on 29th Oct'26 in Chennai to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. Additionally, in compliance with SEBI insider trading regulations, the trading window for dealing in the company's equity shares by designated persons and their immediate relatives remains closed until 31st Oct'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 29 Oct 2026, 5:30 am
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP
Encumbered Shares - Invocation / Release · 15 Oct 2026, 8:48 pm
Chemikas Speciality Pledges Additional Stake in Archean Chemical Industries Promoter Chemikas Speciality LLP created fresh pledges on a total of 10,87,500 shares (0.881% of total share capital) of Archean Chemical Industries Ltd on 17th Sep'26 as loan collateral. This includes 3,88,000 shares (0.314%) pledged to Piramal Finance/Piramal Trusteeship Services and 6,99,500 shares (0.567%) pledged to JM Financial Credit Solutions. Following these transactions, Chemikas Speciality's total encumbered holding increased from 1,39,80,010 shares (11.32% of total capital) to 1,50,67,510 shares (12.20% of total capital). Chemikas Speciality holds a 30.53% total stake in the company.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas ....
Encumbered Shares - Invocation / Release · 15 Oct 2026, 8:45 pm
Chemikas Speciality Pledges Shares of Archean Chemical Industries Promoter Chemikas Speciality LLP created a pledge on 30,000 equity shares (0.024% of total share capital; 0.080% of its holding) of Archean Chemical Industries Ltd. on 1st Sep'26 as collateral for loans in favor of Piramal Finance Ltd. / Piramal Trusteeship Services Pvt. Ltd. Following this transaction, Chemikas Speciality's total encumbered holding stands at 1,39,80,010 shares, representing 11.32% of the company's total equity base, out of its overall 30.53% stake (3,76,93,219 shares).
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 23, 2026 for Chemikas Speciality LLP
Encumbered Shares - Invocation / Release · 23 Sept 2026, 5:19 pm
Chemikas Speciality Pledges Additional Stake in Archean Chemical Industries Promoter Chemikas Speciality LLP created fresh pledges on 10.87 lakh shares (0.88% of total share capital) of Archean Chemical Industries on 17th Sep'26 as collateral for loans. This includes 3.88 lakh shares (0.314%) pledged to Piramal Trusteeship Services and 6.99 lakh shares (0.567%) to JM Financial Credit Solutions. Consequently, Chemikas Speciality's total encumbered holding increased from 1.398 cr shares (11.32%) to 1.506 cr shares, representing 12.20% of the company's total equity base out of its 30.53% overall stake.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP
Encumbered Shares - Invocation / Release · 09 Sept 2026, 11:23 pm
Archean Chemical Promoter Chemikas Speciality Pledges Shares Chemikas Speciality LLP, promoter of Archean Chemical Industries Ltd, created a pledge on 30,000 equity shares (0.024% of total share capital) on 1st Sep'26 as loan collateral in favor of Piramal Trusteeship Services Private Limited. Following this transaction, Chemikas Speciality's total encumbered holding increased from 1,39,50,010 shares (11.30% of total capital) to 1,39,80,010 shares, representing 11.32% of Archean Chemical's total share capital. Total promoter holding for Chemikas Speciality stands at 3,76,93,219 shares (30.53%).
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
Acquisition/ Disposal of Shares · 05 Sept 2026, 4:52 pm
SBI Mutual Fund Trims Stake in Archean Chemical Industries to 4.34% SBI Mutual Fund reduced its shareholding in Archean Chemical Industries Ltd by selling 1,47,599 equity shares (0.1196% stake) via market sale on 3rd Sep'26. Following the transaction, SBI Mutual Fund's aggregate holding across various schemes decreased to 53,63,574 shares, representing 4.3444% of the company's total paid-up equity capital, down from 4.4640% prior to the sale. The transaction triggered disclosure requirements under SEBI regulations as the cumulative holding decreased by over 2% from its previously reported level of 6.4616% on 22nd Nov'22.
Earnings call Transcript
Transcript · 07 Aug 2026, 9:25 pm
Earnings Call Recording
Audio / Video · 04 Aug 2026, 12:24 am
Archean Chemical Makes Q1 FY27 Earnings Call Recording Available Archean Chemical Industries has released the audio recording of its earnings conference call for the quarter ended Jun 30, 2026. The call was held on Aug 03, 2026, at 11:00 am. The recording is now accessible on the company's website under the investor relations section. This follows the firm's earlier intimation dated Jul 28, 2026, regarding the scheduled call.
Investor Presentation
Investor Presentation · 01 Aug 2026, 11:48 pm
Archean Chemical Q1FY27: Bromine Strength Offsets Salt Weakness Archean Chemical's Q1FY27 consolidated revenue rose to Rs. 3,328 Mn, with PAT at Rs. 304 Mn. Strong Bromine segment performance, with revenue up 58% YoY to Rs. 1,333 Mn, drove growth. This was offset by a 12% YoY decline in Industrial Salt revenue to Rs. 1,713 Mn due to logistical challenges and higher costs. The Bromine Derivatives business (Acume) grew 28% to Rs. 296 Mn, turning EBITDA-positive at Rs. 19 Mn. Consolidated EBITDA fell 16% YoY to Rs. 729 Mn.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP
Encumbered Shares - Invocation / Release · 31 Jul 2026, 10:47 pm
Archean Chemical: Promoter Chemikas Speciality Releases Pledged Shares Promoter entity Chemikas Speciality LLP released a pledge on 5,200 shares of Archean Chemical Industries on 22nd Jul'26. This release, representing 0.004% of the company's total capital, was executed after repaying a loan to JM Financial Products Limited. Following this transaction, Chemikas Speciality LLP's total encumbered holding decreased to 1,39,47,010 shares, which is 11.30% of their total holding. The disclosure was made to the exchanges on 23rd Jul'26.
Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.
Financial Result · 31 Jul 2026, 2:04 am
Archean Chemical Q1FY27: Revenue Rises, But Profitability Declines YoY Archean Chemical reported consolidated results for Q1FY27 ending 30 Jun'26. Revenue from operations grew 11.9% YoY to ₹32,719.81 lakhs. However, Profit Before Tax (PBT) declined 23.8% YoY to ₹4,421.93 lakhs, and Profit After Tax (PAT) fell 24.4% YoY to ₹3,035.44 lakhs. Sequentially, PAT more than doubled from ₹1,222.80 lakhs in Q4FY26. The consolidated basic EPS for the quarter stood at ₹2.48, down from ₹3.25 in the prior-year quarter but up from ₹1.13 in the preceding quarter.
Outcome of the Board Meeting held on July 30, 2026 1. The Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Pursuant to Regulation 33(3) of ....
Outcome · 31 Jul 2026, 2:00 am
Archean Chemical Industries Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 32,720 (+11.9% YoY | +8.7% QoQ) ■ EBITDA: 6,726 (-13.9% YoY | +53.9% QoQ) ■ EBITDA Margin (%): 20.6 (-615 bps YoY | +604 bps QoQ) ■ PAT: 3,068 (-23.7% YoY | +128.6% QoQ) ■ EPS (INR): 2.48 (-23.7% YoY | +121.4% QoQ)
Intimation of Schedule for Earnings Call
Intimation · 03 Aug 2026, 11:00 am
Archean Chemical Sets Q1 FY27 Earnings Call for August 3 Archean Chemical Industries (NSE: ACI) has scheduled its earnings call to discuss financial results for the quarter ended Jun 30, '26 (Q1 FY27). The call will take place on Mon, Aug 03, '26, at 11:00 AM IST. Key management, including the Managing Director and CFO, will participate to discuss the company's operational and financial performance. This event follows the official announcement of the quarterly results.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2026 for Chemikas Speciality LLP
Encumbered Shares - Invocation / Release · 24 Jul 2026, 3:42 pm
Archean Chemical: Promoter Chemikas Speciality LLP Releases Pledged Shares Promoter entity Chemikas Speciality LLP has released a pledge on 5,200 shares, equivalent to 0.004% of Archean Chemical's total capital. The release, effective 22nd Jul'26, occurred after the repayment of a loan from JM Financial Products Limited. Following this transaction, the total number of shares encumbered by the promoter stands at 1,39,50,010, which constitutes 11.30% of the company’s capital. The de-pledging by a promoter is generally viewed as a positive signal, indicating improved financial standing.